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Abstract
Background: Protein disulfide isomerase (PDI), is sorted to be enzymatic chaperone for reconstructing misfolded protein in
endoplasmic reticulum lumen. Recently, PDI has been identified as a link between misfolded protein and neuron apoptosis.
However, the potential for PDI to be involved in the pathogenesis of prion disease remains unknown. In this study, we
propose that PDI may function as a pleiotropic regulator in the cytotoxicity induced by mutated prion proteins and in the
pathogenesis of prion diseases.
Methodology/Principal Findings: To elucidate potential alterations of PDI in prion diseases, the levels of PDI and relevant
apoptotic executors in 263K infected hamsters brain tissues were evaluated with the use of Western blots. Abnormal
upregulation of PDI, Grp78 and Grp58 was detected. Dynamic assays of PDI alteration identified that the upregulation of PDI
started at the early stage and persistently increased till later stage. Obvious increases of PDI and Grp78 levels were also
observed in cultured cells transiently expressing PrP mutants, PrP-KDEL or PrP-PG15, accompanied by significant
cytotoxicities. Excessive expression of PDI partially eased ER stress and cell apoptosis caused by accumulation of PrP-KDEL,
but had less effect on cytotoxicity induced by PrP-PG15. Knockdown of endogenous PDI significantly amended cytotoxicity
of PrP-PG15, but had little influence on that of PrP-KDEL. A series of membrane potential assays found that apoptosis
induced by misfolded PrP proteins could be regulated by PDI via mitochondrial dysfunction. Moreover, biotin-switch assays
demonstrated active S-nitrosylted modifications of PDI (SNO-PDI) both in the brains of scrapie-infected rodents and in the
cells with misfolded PrP proteins.
Conclusion/Significance: Current data in this study highlight that PDI and its relevant executors may function as
a pleiotropic regulator in the processes of different misfolded PrP proteins and at different stages during prion infection.
SNO-PDI may feed as an accomplice for PDI apoptosis.
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Introduction
Prion disorders, or transmissible spongiform encephalopathies
(TSEs), are fatal neurodegenerative diseases affecting humans and
many species of animals, for example Creutzfeldt-Jakob disease
(CJD) in humans, scrapie in sheep and goat, and bovine
spongiform encephalopathy (BSE) in cattle. Prion-related disorders
share common neuropathology characteristics, such as spongiform
degeneration, extensive neuronal loss and the accumulation of
PrP
Sc, a misfolded and protease-resistant form of the normal prion
protein (PrP
C) [1]. Although the mechanism of PrP
Sc pathogenesis
is still controversial, mounting evidences suggests that perturba-
tions in endoplasmic reticulum (ER) homeostasis or mitochondrial
dysfunction induced by PrP
Sc or misfolded prion proteins may
contribute to cell death or neurodegenerative pathology in prion
disease [2,3,4].
When ER homeostasis is perturbed, ER stress triggers the
survival pathway, unfolding protein response (UPR), which is
associated with upregulation of ER-derived chaperones and
protein-folding enzymes leading the misfolded proteins undergo-
ing the process of degeneration [5,6]. Conventionally, activation
of UPR increase pro-survival effects including an increased
expression of the glucose-related protein (Grp) family, such as
Grp78/Bip, and chaperones with protein disulfide isomerase
(PDI) -like activities, such as PDI and Grp58 (also known as
PDIA3) [7]. In the terminal stage of the scrapie-infected murine
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stress response. Moreover, Grp58 and its structural homolog PDI
have neuroprotective activities against ischemia [8]. On the other
hand, when ER homeostasis cannot be restored, the pro-
apoptotic process is irreversiblely induced, executed by ER-
resident caspase-12 or caspase-3 in the cytoplasm [9]. Interest-
ingly, it was revealed that PDI and Grp58 were also involved in
apoptosis induced by misfolded proteins [10]. Although the PDI-
mediated apoptotic pathway seems to be specific for misfolded
proteins, the role of PDI in prion-related diseases or misfolded
PrPs remains unclear.
PDI is a target of nitrosative stress, which results in S-
nitrosylation of normal PDI. S-nitrosylated PDI (SNO-PDI) has
been found in the brains of patients with Parkinson’s disease and
Alzheimer’s disease, which are commonly characterized by
intracellular or extracellular accumulation of misfolded proteins
[11]. Under conditions of severe nitrosative stress, SNO-PDI can
prolong the UPR, thus contributing to aberrant protein
accumulation and cell damage [11]. In the model of Hunting-
ton’s disease, PDI has been identified as a regulator for a cell
death pathway [10]. Chemicals that limit the activity of PDI, or
shRNAs that down-regulate PDI expression, ultimately provide
a protective benefit for cells displaying misfolded protein.
However, the potential alteration of SNO-PDI in prion diseases
remains to be documented.
In the present study, we investigated the functional relationship
between PDI and misfolded PrP proteins in the induction of ER
stress, mitochondria dysfunction and the apoptotic process, by
measuring the potential changes of relative markers either in
scrapie-infected brain tissues or in cell models transiently
expressing two human PrP mutants, PrP-KDEL, which can be
retained in ER with an artificial KDEL tag mimicking PrP
mutants within the transmembrane region [12], and PrP-PG15,
which contains 10 extra-octarepeat insertions mimicking human
genetic prion-disease- associated PrP insertions within the
octarepeat region. Our results demonstrated abnormally increased
PDI family members in the brains of scrapie-infected hamsters and
in cells expressing misfolded PrP mutants. Overexpression of
misfolded PrP in cells upregulated the level of PDI seems to be
a two-character event. Excessive expression of PDI eased ER stress
and cell apoptosis caused by accumulation of the PrP mutant in
ER, but had less effect on cytotoxicity induced by PrP mutants
with extra-octarepeat insertions. Knockdown of endogenous PDI
significantly amended cytotoxicity caused by PrP with extra-
octarepeat insertion, but had little influence on the cytotoxicity
induced by PrP mutants anchored in the ER. We also
demonstrated that mitochondrial dysfunction contributed to the
PrP-mutants-induced apoptotic effect, and S-nitrosylation of PDI
plays an essential role in PDI-mediated cytotoxicity.
Materials and Methods
Antibodies
The following antibodies were used in this study, including
anti-actin mouse monoclonal antibody (mAb), anti-cytochrome c
rabbit polyclonal antibody (pAb), anti-VDAC1 mouse mAb, anti-
Bcl-2 pAb, anti-Bax mAb and anti-PDI pAb (Santa Cruz (USA);
anti-pro-caspase-3, anti-pro-caspase-12, anti-GRP58, and anti-
GRP78/Bip (Abcam, Hong Kong); PrP specific mAb 3F4 (Dako,
Denmark); HRP-conjugated anti-rabbit or anti-mouse immuno-
globulin G (Boehringer, Germany); and FITC-conjugated anti-
mouse IgG and Alexa Fluor 568 goat anti-rabbit IgG (Invitrogen,
USA).
Ethics Statement
The use of animal specimens in this study was approved by the
Ethical Committee of the National Institute for Viral Disease
Prevention and Control, China CDC under protocol
2009ZX10004-101. All signed informed consents forms were
collected and stored by the China CJD Surveillance Centre. All
Chinese golden hamsters were maintained under clean grade.
Housing and experimental protocols were in accordance with the
Chinese Regulations for the Administration of Affairs Concerning
Experimental Animals.
Preparation of Brain Tissue Samples
Four Chinese golden hamsters (innoculated intracerebrally with
hamster-adapted scrapie agent 263K ) and three normal hamsters
were enrolled in this study. Brain homogenates (10%, w/v) were
prepared based on the protocol described previously [13]. Briefly,
brain tissues were homogenized in lysis buffer (100 mM NaCl,
10 mM EDTA, 0.5% Nonidet P-40, 0.5% sodium deoxycholate,
10 mM Tris, pH 7.5) containing a mixture of protease inhibitors.
The tissue debris was removed with low-speed centrifugation at
2,000 g for 10 min and the supernatants were collected for further
study.
Plasmids and Cell Transfection
The full-length human PDI complementary DNA (cDNA ) was
amplified by a polymerase chain reaction (PCR ) protocol, with
the specific primers (59-CGCGGATC-
CATGCTGCGCCGCGCTCTGCT-39, with a BamHI site
underlined) and (59-CCGGAATTCTTTACAGTTCATCTTT-
CACAGCTT-39, with an EcoRI site underlined) from the reverse
transcripts of the RNA extracted from cultured 293T cells. PCR
was conducted under the following conditions, 94uC for 30s, 55uC
for 30s and 72uC for 30s, for a total of 30 cycles. The amplicon
was digested with BamHI and EcoRI and cloned into vector
pcDNA3.1, generating plasmid pcDNA-PDI. Recombinant plas-
mids pcDNA-PrP-WT (previously named as pcDNA-PrP-PG5),
pcDNA-PrP-G114V, pcDNA-PrP-PG14, pcDNA-PrP-PG-15,
pcDNA-PrP-KDEL and pcDNA-PS1-KDEL were constructed
previously [12,14].
Small interfering RNA oligonucleotides (oligo) targeting human
PDI RNA were synthesized by GenePharma (Shanghai, China) as
followes: PDI-1003-sense strand: 59-GGCAAACUGAGCAA-
CUUCATT-39 and PDI-1003-antisense strand: 59-UGAA-
GUUGCUCAGUUUGCCTT-39. The transfection procedure
was performed as previously described [12]. Briefly, monolayer
cell line 293-T was maintained in DMEM (Gibco BRL, USA).
Cells were plated onto 12-well or 96-well plates (Corning, USA)
24 h before transfection. Various recombinant plasmids or RNA
oligo (1 mg DNA or 40 pmol RNA oligo per well in 12-well plates;
0.1 mg DNA or 5 pmol RNA oligo per well in 96-well plates ) were
transfected with FuGENE
H HD reagent (Roche, Switzerland)
according to the manufacturer’s instructions. A GFP expressing
plasmid, pcDNA-GFP, was used to estimate the efficacy of
transfection. 48 h post-transfection, cells were harvested in RIPA
lysis buffer (Beyotime Institute of Biochemistry, China) by cell
scraper.
Isolation of Cytosolic Fraction
Cell fractions were isolated by a commercial Qproteome
mitochondria isolation kit (Qiagen, Germany). Briefly, all grouped
cells were stripped by trypsin digestion, and washed with 0.9%
sodium chloride solution once. Aliquots of the lysis buffer
containing protease inhibitor solution were added in order to
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ice-acetone and maintained at 220uC for 1 h. After Centrifuging
at 12000 g for 10 min, the pellet was resuspended carefully with
ice-cold disrupting buffer using a syringe with blunt-ended needle
carefully. The preparation was spun at 6000 g for 10 min and the
pellet was collected as the fraction of mitochondria.
SDS-PAGE and Western Blot Analysis
Aliquots of each sample were prepared for 15% sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) by addi-
tion of 5 times loading buffer. Samples with loading buffer were
heated for 10 min, following electrophoresis; the fractionated
proteins were transferred to nitrocellulose (NC) membranes
(Whatman, USA) by the semi-dry method in transfer buffer. After
there were blocked with 5% non-fat milk powder in TBST buffer,
membranes were incubated with the individual primary antibodies
at room temperature for 2 h. Membranes were subsequently
incubated with different HRP-conjugated secondary antibodies
and reactive signals were visualized using an enhanced chemilu-
minescence kit (Amersham-Pharmacia Biotech, USA).
Mitochondrial Membrane Potential Assay
The situations of the mitochondrial transmembrane transition
in live cells were determined with the use of a commercial kit
(MitoCapture
TM Mitochondrial Apoptosis Detection kit, BioVi-
sion), following the manufacturer’s instructions. Growing cells
(about 60% confluence) were transiently transfected with various
recombinant plasmids or RNA oligo. Cells were collected 30 h
after transfection and resuspended in 1 ml diluting MitoCapture
solution, followed by incubation at 37uC for 20 min. After a short
spinning, the cells were resuspended in 1 ml pre-warmed
incubation buffer. Cells were mounted onto glass slips and
examined under a fluorescence microscope (Olympus BX51,
Japan).
The ratios of positive cells with green fluorescence were
determined with flow cytometry that monitored the signal of
FITC and PI channels simultaneously. Briefly, 48 h after trans-
fection, cells were harvested and resuspended in 1 ml diluting
MitoCapture solution, followed by incubation at 37uC for 20 min.
Samples were analyzed on a FACScan flow cytometer (Becton
Dickinson, Oxford, UK). Fluorescence was measured through
a 530/30 band filter (FL-1) to monitor FITC and through a 585/
42 band filter (FL-2) to monitor PI uptake.
Caspase-3 Activity Assay
Caspase-3 activity was measured according to a colorimetric
protocol based on the manufacturer’s instructions (Calbiochem,
USA). Briefly, 1610
6 cells were transfected with various constructs
or challenged with PDI-specific siRNA, 48 h later, cells were
harvested and cell extracts were prepared. Under an ice bath, Ac-
DEVE-pNA used as the substrate for activated caspase-3 was
mixed with aliquots of cells extracts. Reactions were conducted in
96-well plates at 37uC for 120 min in the dark. Absorbance was
determined with a microELISA plate reader (Thermo MK3, USA)
at 405 nm. A recombinant human caspase-3 provided in the kit
was used as positive control.
Cell Viability Assay
Cell viability was determined with the use of a CCK-8 cell
counting kit (Dnjindo, Japan). Briefly, cells were treated according
to the assigned protocol and mixed with 10 ml CCK-8 reagent in
each well at 37uC for 1 h. Absorbance was measured at 450 nm
with a spectrophotometer. Each experiment was performed in
triplicate and repeated at least three times.
Immunocytochemistry
Cells adhered to coverslips were fixed with 4% paraformalde-
hyde (PFA) at room temperature for 10 min and permeabilized
with 0.5% Triton X-100 for 5 min. Nonspecific binding was
minimized by incubation in the blocking solution (10% bovine
fetal serum in PBS) at 37uC for 1 h. Cells were incubated with the
1:500 diluted PrP mAb 3F4 and PDI pAb at 37uC for 2 h. the cells
were washed with PBS, then incubated with anti-mouse and anti-
rabbit antibodies conjugated with FITC 488/Alexa Fluor 568 at
37uC for 1 h. Cell nuclei were fluorescently stained with DAPI
dye. For Golgi staining, cells incubated with the 1:500 diluted PrP
mAb 3F4 and anti-mouse antibody conjugated with FITC-488
were further stained with DAPI dye and Golgi-Tracker Red
(Beyotime Institute of Biochemistry, China) at 4uC for 30 min.
The images of cells were visualized with the use of a confocal
microscopy (Leica ST2, Germany).
Biotin-switch Assay for Detecting S-nitrosylated Protein
S-nitrosylation of proteins in brain tissues and in cell lysates was
performed with a commercial detection assay kit (Cayman
Chemical, USA) according to the manufacture’s instructions.
Briefly, cell lysates and brain tissue homogenates were mixed with
the blocking buffer, gently agitating the mixture at 4uC for 30
minutes to block free thiol groups. The blocking agent was
replaced with ice-cold acetone precipitation at 220uC, and the
nitrosothiols were reduced to thiols with a reducing reagent. The
newly formed thiols were labeled with a biotinylating reagent. The
total biotinylated proteins were immunoprecipitated with strepta-
vidin-agarose beads. and SNO-PDI was detected with Western
blots.
Statistical Analysis
Based on quality control, any experimental data used for
quantitative analysis were repeated at least three times. Data were
analyzed by a parametric T test (two tailed), and P values less than
0.05 were considered to be statistically significant. When more
than two groups were analyzed, an ANOVA test with the SPSS
17.0 statistical package was also used to estimate statistical
significance. All quantitative analyses of immunoblot images were
carried out using software Image J.
Results
Upregulation of PDI Proteins during Scrapie Experimental
Infection
To assess the possible change of PDI in the brains with prion
disease, the levels of some PDI family members in hamsters brain
tissues infected with scrapie strain 263K were evaluated with
individual Western blots. Obvious PK-resistant PrP signals (PrP
res)
were detected in infected hamsters brains collected at the terminal
stage, which were collected about 60 to 70 days post-inoculation
(dpi) (Fig. 1A). Two candidates from the PDI family, Grp58 and
PDI as well as another ER-anchored chaperone Grp78/Bip were
individually detected with the dependable specimens. Significant
upregulation in the expression levels of Grp78/Bip, Grp58, and
PDI were detected in the samples of infected hamsters (Fig. 1B).
Mean relative gray values of three ER makers in scrapie-infected
animals showed statistical differences compared with that of
normal controls, after they were normalized with individual data
from b-actin (Fig 1C). Additionally, the amounts of pro-Caspase3
Roles of PDI in Prion Toxicity
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than that of controls (Fig 1, B and C), revealing signs of apoptosis.
To address the dynamic alteration of PDIs in the brains of
scrapie experimental hamsters during the incubation period, the
levels of various PDIs in the agent 263K-infected hamster brain
samples collected on the 20
th,4 0
th and 60
th dpi were compara-
tively analyzed with Western blots. Signals from Grp78, Grp58
and PDI levels were clearly upregulated on 20 dpi, increasing until
reaching a maximum on 60 dpi, whereas the levels of pro-CASP3
were decreased from 40 dpi and the signal of cleavage-CASP3 was
observed on 60 dpi (Fig 1D and E). These results illustrate that
UPR activation and increased expression of PDIs initially begin at
the early stage of scrapie infection. Even at the terminal stage of
the scrapie-infected animals, PDIs are still keep to be upregulated,
accompanied by activation of caspase-3.
Abnormality of Misfolded PrP Mutants in the Cell Models
Our previous studies demonstrated that transient expressions of
the PrP construct retained in ER (PrP-KDEL) and PrP with extra-
octarepeats insertions [15] on the cultured cells induced ER stress
and cell apoptosis. To obtain more detailed insight into the
involvement of PDI in the prion-associated abnormality, recom-
binant plasmids expressing wild-type PrP (pcDNA-PrP-WT), PrP
with additional ER-anchored peptide (pcDNA-PrP-KDEL) and
PrP with 10 extra-octarepeats (pcDNA-PrP-PG15) were individ-
ually introduced into 293-T cells that were confirmed without
detectable endogenous PrP
C in routine Western blot assays [15].
Clear PrP-specific signals were observed in the cells receiving the
various PrP-expressing plasmids, in which wild-type PrP (PrP
WT)
and PrP with additional ER-anchored peptide (PrP
KDEL) migrated
at the same position (ranging from 25 to 35 kDa), while PrP with
ten extra-octarepeats (PrP
PG15) at the position from 35 to 45 kDa
(Fig 2A).
To see the subcellular locations of the expressed PrPs as well as
their co-locations with cellular endogenous PDI, cells transiently
transfected with different PrP constructs were subjected to
immunocytochemical assays. Confocal microscopy identified that
the signal for PrP
WT (green) mainly distributed in the plasma
membrane, which did not co-localized with the signal for PDI in
cytoplasm (red) (Fig. 2B, top). The expressed PrP
KDEL displayed
on plasma membrane and in cytoplasm, but mainly concentrated
as plaque-like structures in the cytoplasm, which co-localized well
with the PDI positive signal on the ER (Fig. 2B, middle ). Signals
for PrP
PG15 were observed both on plasma membrane and in
cytoplasm, and among them, the plaque-like structure accumu-
lated on the ER and in the perinuclear compartment overlapped
with the signal for PDI (Fig. 2B, bottom).
It has been suggested that disease-causing mutated PrP will
experience post-ER metabolism, trafficking to the Golgi apparatus
[16]. To see the relationship between expressed PrPs and the
Golgi body, cells receiving various PrP constructs were double-
stained with PrP-specific mAb and Golgi-Tracker Red. The
expressed PrP
WT appeared not tp overlap with signals from the
Golgi body, whereas both expressed PrP mutants, especially
PrP
KDEL, partially overlapped with Golgi-positive signals (Supple-
mental Fig S1). It seems that expressed PrP mutants have
a stronger disposition to accumulate in cytoplasm organelles, such
as reticulum organelles, the perinuclear inclusion compartment
and Golgi apparatus, and to co-localize with PDI, which may
Figure 1. Comparative analysis of the levels of PDIs in the brain tissues of normal and 263K-infected hamsters. A. Western blots. The
infected hamsters were collected about 60 to 70 dpi. Same amounts of individual brain homogenate were loaded in 15% SDS-PAGE and
immunoblotted with PrP specific mAb 3F4. PK+: with PK (50 mg/ml); PK-: without PK. B. Western blots of Grp78, Grp58, PDI and pro-caspase3.
C. Quantitative analysis of each gray numerical value of Grp78, Grp58, PDI and pro-caspase3 vs that of individual b-actin. The average values are
calculated from four infected hamsters or three normal hamsters and presented as mean 6 SD. Statistical differences compared with controls are
illustrated. D, Dynamic analyses of Grp78, Grp58, PDIs, pro-caspase3 and cleveage-caspase3 in the brain tissues of scrapie agent 263K-infected
hamsters collected on 0, 20, 40 and 60 dpi during incubation period with Western blots. E. Log-fold changes of the gray values of Grp78, Grp58, PDIs,
pro-caspase3 in the 263K-infected hamster’s brains collected on 20, 40 and 60 dpi vs that of 0 dpi.
doi:10.1371/journal.pone.0038221.g001
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tion process.
Misfolded Prion Proteins Induced Cell Death through ER
Stress and Activation of Caspases
Previous studies have repeatedly confirmed that transient
expressions of PrP-KEDL and PrPs with extra-octarepeat inser-
tions cause cell apoptosis and pathological abnormality in animal
models or cell lines [17,18,19]. Under these experimental
conditions, expressions of PrP-KEDL and PrP-PG15 in 293-T
cells significantly decreased cell viability (Fig. 3A). To see the
changes in cellular agents related to ER stress and apoptosis, cells
receiving different PrP constructs were harvested 48 h posttrans-
fection and levels of individual molecules were evaluated by
Western blots. In line with the observation in scrapie-infected
hamsters, the levels of two ER-chaperone members, Grp78 and
PDI, were markedly increased in cells expressing PrP-KEDL and
PrP-PG15, whereas that in cells expressing wild-type PrP
remained unchanged compared with the mock (Fig. 3B and C).
Consistent with that, an executor of ER apoptosis, caspase-12, was
activated by expressions of abnormal PrPs, which possessed
a significant decrease in its precursor (Fig. 3C). Meanwhile, levels
of pro-caspase-3 were downregulated, whereas that of Bax were
upregulated in cells expressing those two PrP mutants, represent-
ing activation of the apoptotic executors caspase-3 and Bax
(Fig. 3C and D). Those results indicate that ER stress and caspase
activation contribute to PrP-KEDL and PrP-PG15-induced
cytotoxicity.
To exclude the possible influence of the KDEL tag, a mamma-
lian-expressing plasmid encoding full-length presenilin 1 (PS1)
with an extra amino acid KDEL at the C-terminus (PS1-KDEL)
was introduced into 293-T cells. As expected, expression of PS1-
KDEL did not induce detectable cytotoxicity (Supplemental Fig
S2A) and remarkable changes of the tested biomarkers for ER-
stress and apoptosis (Supplemental Fig S2B and C). To profoundly
present the associations of those two PrP mutants with natural
familial CJD (fCJD) related PrPs, two human mutated PrP
constructs, PrP-G114V with a glycine-to-valine exchange at the
position of amino acid.114 within the transmembrane region and
PrP-PG14 with nine extra-octarepeat insertions, were transiently
expressed in 293-T cells. In line with the previous results [12,15],
obvious cytotoxicities were observed in the cells expressing PrP-
G114V and PrP-PG14 (Supplemental Fig S2A). Western blot
assays showed significant increases in levels of PDI and Grp78 and
decreases in that of pro-CASP12 and pro-CASP3 in cells
expressing PrP-G114V and PrP-PG14, which were similar to that
of PrP-KEDL (Supplemental Fig S2B and C).
Overexpression of PDI Functioned as a Survival Factor for
Cells Expressing PrP Mutants Accumulated in the ER
To see the potential role of PDI in misfolded PrP-induced
cytotoxicity, a PDI-expressing plasmid was introduced into the
cell model to create a situation of overexpression of PDI.
Western blots revealed that transfection of pcDNA-PDI increased
cellular PDI levels but did not influence levels of expressed PrPs
when co-transfected with different PrP-expressing plasmids
(Fig 4A). CCK-8 assays showed that transient expression of
PDI alone did not affect cell growth, which revealed cell viability
similar to mock and the preparation of wild-type PrP (Fig 4B).
Co-transfection of the plasmid-expressing PDI and PrP mutants
reversed to a modest degree PrP mutants-induced cytotoxicity,
but showed distinct effectiveness, in which overexpression of PDI
rescued PrP
KDEL- induced cytotoxicity with statistical significance
but seemed to have less effect on PrP
PG15-induced cytotoxicity
Figure 2. Expressions of transiently transfected PrP constructs and co-localizations of the expressed PrPs with PDI in 293-T cells. A.
Western blots of the expressions of wild-type PrP (PrP
WT) and PrP mutants (PrP
KDEL and PrP
PG15). B. Immunocytochemial assays of the cells transfected
with various PrP constructs 48 h after transfection. The images of PrP (green), PDI (red), DAPI (blue) and merge are monitored under a confocal
microscopy and indicated above. (61000).
doi:10.1371/journal.pone.0038221.g002
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preparation co-expressing PDI and PrP
KDEL, the levels of Grp78,
pro-caspase-12, and pro-caspase-3 recovered to a degree com-
parable to the control, whereas levels of pro-caspase-3 in the
preparation co-expressing PDI and PrP
PG15 were obviously lower
than the controls (Fig 4C and D). Additionally, levels of Bax in
those two preparations were still higher than controls (Fig. 4E). It
seems that overexpression of PDI in cultured cells sufficiently
releases ER stress and antagonizes apoptosis induced by
misfolded PrP mainly accumulated in the ER, but has a limited
effect on the apoptosis of other organelles.
Knockdown of Endogenous PDI Rescued Apoptosis
Induced by PrP Mutants with Octarepeat Insertions
To determine the effectiveness of removal of PDI on the release
of ER stress caused by expressions of PrP mutants, PDI-specific
siRNAs were synthesized and introduced into 293-T cells.
Evaluation of expression levels of cellular PDI by Western blot
Figure 3. Influences of expression of various PrP constructs on the cell viability and the relevant cellular factors. A. Cell viabilities
assayed by CCK-8 kit. Each group is assigned to three repeating parallel units and measured with a spectrophotometer under 450 nm. The results are
calculated from three independent tests and indicated as mean 6 SD. Statistical differences compared with controls are illustrated as *P,0.05.
B. Western blots. Cell lysates were separated in 15% SDS-PAGE and the specific immunoblots for Grp78, pro-caspase12, PDI, pro-caspase3, Bcl-2 and
Bax were detected with individual antibodies. C. Quantitative analysis of each gray numerical value of Grp78, pro-caspase12, PDI, pro-caspase3 vs that
of individual b-actin. The results are calculated from three independent tests and presented as mean 6 SD. Statistical differences compared with
controls are illustrated as *P,0.05. D. The relative densities of Bcl-2 and Bax specific bands normalized to b-actin are presented as ratio of Bax/Bcl-2.
Statistical differences compared with controls are illustrated.
doi:10.1371/journal.pone.0038221.g003
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specific siRNA, caused roughly 40 to 60% reduction in expression
of endogenous PDI, but did not affect PrP levels when co-
transfected with different PrP-expressing plasmids (Fig 5A). CCK-
8 assays did not reveal remarkable cytotoxicity on cultured cells
after introduction of PDI-specific siRNA (Fig 5B). Co-expression
of PrP
KEDL with PDI-specific siRNA induced slightly lower cell
viability than the expression of PrP
KEDL alone, but without
statistical difference (Fig 5B). However, co-expression of PrP
PG15
with PDI-specific siRNA did not aggravate, but improved
PrP
PG15-induced cytotoxicity (Fig 5B). Western blots revealed
downregulated pro-caspase 3 and Bcl-2, and upregulated Bax in
cells receiving plasmid-expressing PrP
KEDL and PDI-specific
siRNA, and levels of molecules tested in cells receiving PrP
PG15
and PDI-specific siRNA comparable to that of the control (Fig 5C,
D and E). These data suggest that knockingdown endogenous PDI
produces different effects on those two PrP mutants.
PDI Involved in Mitochondrial Dysfunction Induced by
Misfolded Prion
Organelle-specific initiation of cell death can be induced by
various misfolded proteins based on different situations [20,21].
To identify the involvement of mitochondrial dysfunction in
apoptosis induced by those two PrP mutants, the mitochondrial
transmembrane potentials (MTP) of the cells challenged with PrP
mutants under conditions of overexpressing or downregulating
PDI were evaluated. With the help of a commercial mitocapture
kit that could distinguish the apoptotic cells (green) with
mitochondria dysfunction from the live cells (red), more green-
stained cells were observed in preparations of PrP
KDEL and
PrP
PG15, showing statistical significance after comparing percent-
ages of apoptotic cells in preparations of PrP mutants with that of
PrP
WT (Fig. 6A and B). Furthermore, levels of cytochrome c in
cytoplasm (C-CytC) were measured with Western blots, which
were represented as sequential events of MTP disruption leading
to release of cytochrome c from mitochondria to cytoplasm. In
parallel, the levels of membrane cytochrome c (M-CytC) were
evaluated with Western blots. The cytosolic fraction from crude
lysates was carefully prepared, which was marked with actin and
PDI, but without voltage-dependent anion channel 1 (VDAC1,
a biomarker for the outer membrane of mitochondria, Fig. 6C).
Western blots showed comparable levels of M-CytC in all
preparations (Fig 6D). Interestingly, in the group of transfection
of PrPs alone, cells expressing PrP
KDEL or PrP
PG15 showed
stronger signals of C-CytC than that of PrP
WT and control, with
statistical significance after the digitized gray values of C-CytC
were normalized with that of individual M-CytC (Fig 6 D and E).
Expression of PDI or PDI-specific siRNA alone seemed to not
alter the level of C-CytC (Fig 6D). However, co-expression of PDI
in the cells of PrP
KDEL partially reduced the level of C-CytC but
Figure 4. Influences of overexpression of PDI on PrP mutants-induced cytotoxicity and the alterations of relevant cellular factors. A.
Evaluation of the influence overexpressing PDI on the expressions of various PrP constructs by Western blots. Cell lysates were separated in 15% SDS-
PAGE and the specific immunolots for PDI and PrP were reacted with individual antibodies. B. Cell viabilities assayed by CCK-8 kit. Each group is
assigned to three repeating parallel units and measured with a spectrophotometer under 450 nm. The results are calculated from three independent
tests and indicated as mean 6 SD. Statistical differences compared with controls are illustrated as *P,0.05. C. Western blots. Cell lysates were
separated in 15% SDS-PAGE and the specific immunolots for Grp78, pro-caspase12, PDI, pro-caspase3, Bcl-2 and Bax were detected with individual
antibodies. D. Quantitative analysis of each gray numerical value of Grp78, pro-caspase12, pro-caspase3 vs that of individual b-actin. The results are
calculated from three independent tests and presented as mean 6 SD. Statistical differences compared with controls are illustrated. E. The relative
densities of Bcl-2 and Bax specific bands normalized to b-actin are presented as ratio of Bax/Bcl-2. Statistical differences compared with controls are
illustrated.
doi:10.1371/journal.pone.0038221.g004
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PG15, whereas co-expression of PDI-specific
siRNA in cells of PrP
PG15 remarkably decreased the level of C-
CytC but not in PrP
KDEL (Fig 6D and E). Flow cytometry analysis
revealed that the proportions of apoptotic cells in cells transfected
with plasmids expressing PrP
KDEL and PrP
PG15 alone, the cells co-
expressing PrP
KDEL and PDI-specific siRNA and cells co-
expressing PrP
PG15 and PDI were significantly higher than in
the other preparations (Fig 6F), which were consistent with the
results of assays of cell viability and levels of C-CytC. Assays of the
activities of caspase-3 identified higher enzyme activities in cells
expressing either PrP
KDEL or PrP
PG15, the cells co-challenged with
PrP
KDEL and PDI-specific siRNA, as well as the cells co-expressing
PrP
PG15 and PDI (Fig 6F). Furthermore, the activities of caspase-3
in cells expressing natural fCJD associated PrP mutants (PrP-
G114V and PrP-PG14) were significantly higher than that of
mock, whereas the activity of caspase 3 in cells expressing PS1-
KDEL remained unchanged (Supplemental Fig S3). Those data
imply that, in addition to ER stress and ER-related apoptosis,
mitochondrial dysfunction contributes to apoptosis caused by
expressions of PrP mutants. Changes in cellular PDI levels result in
distinct effects on mitochondria function in cells expressing
different misfolded PrP mutants.
SNO-PDI in Prion Disease and Misfolded Prion Cells
It has been suggested that PDIs can be modified by an S-
nitrosylation process under continuous stress, which is involved in
the pathogenesis of neurodegenerative disease [11]. To probe into
the situation and the contribution of SNO-PDI in prion disease,
levels of SNO-PDI in brain tissues of scrapie-263K-infected
hamsters were screened with a biotin-switch assay. Accompanying
the increases in PDI, a clear SNO-PDI signal was found in two
infected brains but not in normal brains (Fig 7A), suggesting
a disease-related phenomenon. To see this abnormal phenotype in
cell models expressing PrP mutants, cell lysates transfected with
different PrP constructs were subjected to SNO-PDI tests. Obvious
SNO-PDI signals were detected in preparations of PrP
KDEL and
PrP
PG15, but not in that of control and PrP
WT (Fig 7B). In the
presence of L-NMMA, an inhibitor for NO synthase (NOS), no
SNO-PDI signal was detected in all preparations; meanwhile,
neither the expression level of PDI (Fig 7B) nor that of PrP
constructs showed remarkable change compared with those in the
absence of L-NMMA (Fig 7C). It highlights that accumulations of
PrP
KDEL and PrP
PG15 in cytoplasm result in the formation of
SNO-PDI possibly through activating cellular NOS. Further, the
potential protective effect of reduction of SNO-PDI against the
cytotoxicity of those two PrP mutants was evaluated. CCK-8
assays identified that decreased cell viabilities due to misfolded
PrPs were partially, but significantly, recovered by the presence of
Figure 5. Influences of knockdown of endogenous PDI on PrP mutants-induced cytotoxicity and the alterations of relevant cellular
factors. A. Evaluation of the influence down-regulating PDI on the expressions of various PrP constructs by Western blots. Cell lysates were
separated in 15% SDS-PAGE and the specific immunolots for PDI and PrP were reacted with individual antibodies. B. Cell viabilities assayed by CCK-
8 kit. Each group is assigned to three repeating parallel units and measured with a spectrophotometer under 450 nm. The results are calculated from
three independent tests and indicated as mean 6 SD. Statistical differences compared with controls are illustrated as **P,0.001. C. Western blots.
Cell lysates were separated in 15% SDS-PAGE and the specific immunolots for Grp78, pro-caspase12, PDI, pro-caspase3, Bcl-2 and Bax were detected
with individual antibodies. D. Quantitative analysis of each gray numerical value of Grp78, pro-caspase12, pro-caspase3 vs that of individual b-actin.
The results are calculated from three independent tests and presented as mean 6 SD. Statistical differences compared with controls are illustrated.
E. The relative densities of Bcl-2 and Bax specific bands normalized to b-actin are presented as ratio of Bax/Bcl-2. Statistical differences compared with
controls are illustrated.
doi:10.1371/journal.pone.0038221.g005
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partially due to inducement of SNO-PDI.
Discussion
Although the real function of prion protein is still unknown, it is
obvious that deposits of pathogenic or misfolded prion proteins
could result in neuronal damage during the pathogenesis of prion
diseases [22]. It has been well defined that various PrP mutants
induce considerable neuron apoptosis in vitro and in vivo. Many
molecules are identified as pro-apoptotic or anti-apoptotic agents
in prion disease [23,24]. In this artical, time-course studies
revealed that PDI in the brains of infectious prion experimental
animals is upregulated as the disease progression. We also for the
first time provide PDI as a pleiotropic apoptosis regulator in
cytotoxicity induced by two different misfolded prion proteins. In
line with previous publications [25], overexpressions of PrP
mutants in cultured cells can induce serious ER stress and
activation of caspases, and eventually cause apoptosis. Caspase
activation and upregulation of PDIs have been described pre-
viously in the brain of individuals affected by sporadic and variant
CJD and murine scrapie [26,27], which may represent an actively
protective response of the host. By imitating the terminal pattern
of PDIs in infected hamster brains, overexpression of PDI in cells
expressing PrP mutants, especially PrP
KDEL, partially eases the
URP response and caspase-12 mediated ER apoptosis, which
indicates that an increase in PDI to a certain degree releases stress
accumulated in the ER. However, upregulation of endogenous
protective factors, such as Grp58 and PDI, seems not enough to
Figure 6. Assays of mitochondrial dysfunction in the cells expressing various PrP constructs under the condition of overexpression
of PDI or knockdown of endogenous PDI. A. Images of the cells with abnormal mitochondrial transmembrane potentials under a fluorescence
microscopy. Cells under apoptotic process are colored as green and alive cells are red (6200). B. Quantificational analysis of the percentages of
apoptotic cells among the total cells. Data are calculated from three independent tests and presented as mean values 6 SD. Statistical differences
compared with controls are illustrated as *P,0.05. C. Qualitative evaluation of the prepared cell fractions with Western blots of VDAC1 (mitochondrial
maker), PDI (ER maker) and actin (cytosol marker). D. Western blots for C-CytC outflux in the cytosol fractions and M-CtyC in the mitochondrial fraction
of various preparations. The expressing levels of PDI and PrP in the cell lysates of various preparations were also evaluated with individual Western
blots. E. Quantitative analysis of C-CytC with normalizing for mitochondrial membrane-associated Cyt C. Data are calculated from three independent
tests and indicated as mean values 6 SD. Statistical differences compared with controls are illustrated as *P,0.05 or **P,0.001 F. Cytoflowmetry
analysis of the cells with mitochondrial dysfunction each preparation with a mitochondrial apoptosis detection kit. The percentages of apoptotic cells
are shown in Y-axis. Data are calculated from three independent tests and indicated as mean values 6 SD. Statistical differences compared with
controls are illustrated as *P,0.05 or **P,0.001. G. Caspase-3 activity assays of various preparations with a commercial kit. 2 U/ml of recombinant
human capsase-3 (marked as Caspase-3) supplied in the kit was used as the positive control. ABS indicates as absorbance at 405 nm. Data are
calculated from three independent tests and indicated as mean values 6 SD. Statistical differences compared with controls are illustrated as *P,0.05
or **P,0.001.
doi:10.1371/journal.pone.0038221.g006
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damages in prion-infected brains. This is because severe patho-
logical abnormalities and remarkable overexpression of PDI family
members coexist in the brain tissues of scrapie-infected rodents at
the terminal stages. In addition, persistent upregulation of PDI,
Grp58 and UPR-associated Grp78/Bip has been detected in the
pre-symptomatic phage of scrapie-infected hamsters, which may
suggest that the protective effect of such factors is activated at an
early stage [28].
Despite the protective effect of PDIs in prion disease, the
question still remains whether they are involved in apoptotic
pathology at the terminal stage. A pathway of PDIs-associated
apoptosis for misfolded proteinS has been identified in Hunting-
ton’s disease. Excess of PDI can recruit the pro-apoptotic factor in
mitochondria-associated-membrane (MAM) and can result in
a cascade of caspases [10]. In previous work, we proposed that ER
stress in cells expressing various PrP mutants within the trans-
membrane region [12] and with insertional octarepeats [15],
accompanies increases in caspase-3 activity. Moreover, in this
study we repeatedly found evidences of an increase in the Bax/Bcl-
2 ratio and the presences of mitochondrial dysfunction in cells
expressing misfolded prion proteins, accompanied by alteration of
PDI. Activation of caspase-3 also has been detected in the brains of
scrapie-infected hamsters. These observations may highlight an
intrinsic link between upregulation of PDI and mitochondrial
dysfunction in the pathology of prions. On the other hand, some
studies have also proposed that ER stress or ubiquitin-proteasome
system malfunction may not be the direct causative mechanism for
some genetic human prion disease patients and transgenic mice
[29,30]. In XBP-1 KO mice, impaired ER stress is not able to
alert prion replication and its relative pathogenesis [31]. Quaglio,
et al failed to detect ER stress or proteasome dysfunction in
transgenic mice with PrP mutants [29]. One possibility for this
atypical result is that those special sub-populations of PrP mutants
are invisible to the checkpoint of ER-based quality control
machinery, and they selectively experience post-ER metabolism,
termed Golgi-based quality control (Golgi-QC) [16]. Besides ER
retention, PDI-associated mitochondrial malfunction and the
disturbing localization of mutated PrP in the Golgi body,
especially PrP-KDEL, have also been observed in this study.
Therefore, in the process of mutated PrP multimerization,
abnormal regulation of ER-retained chaperones, such as PDIs,
may not only be involved in ER stress, but also in other pathways,
including Golgi-QC.
S-nitrosylated modification of PDI is identified in some
neurodegenerative diseases and is proposed to link with misfolded
proteins in Parkinson’s disease and Alzheimer’s disease [11]. Our
data here illustrate obvious SNO-PDI signals in brain tissues of
scrapie-infected animals, which are undetectable in normal
controls. Our data indicate S-nitrosylation of PDI may be
Figure 7. Detections of SNO-PDI in the brains of scrapie infected hamsters and in the cell models of misfolded prion proteins. A.
Western blots for the PDI and SNO-PDI signals in hamsters’ brains. The biotinylated and immunoprecipitated by streptavidin-agarose beads proteins
from brain homogenates of 263K infected or normal hamsters were separated in 15% SDS-PAGE and blotted with respective specific antibodies.
B. Western blots for the PDI and SNO-PDI signals in the cell models in the presence (+) or absence (-) of L-NMMA. All cells were maintained for 48 h
after transfection and then treated with 1 nM L-NMMA for 6 h. C. Evaluation of the influence of L-NMMA on the expressions of various PrP constructs
by Western blots. Cell lysates were separated in 15% SDS-PAGE and blotted with respective antibodies. D. Cell viability. The results are calculated
from three independent tests indicated as mean 6 SD. Statistical differences compared with controls are illustrated as *P,0.05.
doi:10.1371/journal.pone.0038221.g007
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marked formations of SNO-PDI are observed in cell models of
mutated prion proteins. Blocking the activity of cellular NOS can
not only significantly inhibit formation of SNO-PDI but also
rescue the cytotoxicity induced by misfolded prion proteins. Those
data highlight the formation of SNO-PDI induced by TSE agents
or highlight how misfolded PrP proteins plays critical role in their
cytotoxicity. Based on published documents, it is reasonable to
presume that the expressions of mutated PrP proteins can cause
a dramatic flux of ER calcium content to cytoplasm [3], which
may generate reactive oxygen species (ROS ) and activate NOS in
cells [18]. The release of excessive NO triggers the formation of
SNO-PDI [11,32].
PDI seems to be involved in regulation of misfolded prion
protein in a complicated and pleiotropic manner. At an early
stage, PDI provides with protective activity to eliminate misfolded
proteins; at the late stage, perturbation of oxidative homeostasis
and its inducement of SNO-PDI facilitate PDI-associated apopto-
sis during prion infection. The pleiotropic roles of PDI are also
illustrated in the regulation of cytotoxicity of two distinct mutated
PrP constructs in cell models. PrP
KDEL caused cytotoxicity,
a normal PrP molecular organization with ER-adhering orienta-
tion mimicking PrP mutants within the transmembrane region
[12,33], mostly triggering the abnormal accumulation of PrP in
ER and the malfunction of ER stress. Coexpression of PDI can
partially reverse an increase in the Bax/Bcl-2 ratio and
cytotoxicity induced by PrP
KDEL, whereas downregulation of
cellular PDI aggravates those effects. However, PrP
PG15,a n
abnormal PrP molecular organization with octarepeat insertion
representing a series of genetic CJD-associated insertional mutants
[15,33], is seemingly involved in both ER stress and mitochondrial
apoptosis. The cytotoxitic effect of PrP
PG15 did not seem to be
improved by co-expression of PDI, even when mitochondrial
dysfunction was worsened, whereas down-regulation of cellular
PDI clearly amended PrP
PG15-induced mitochondrial dysfunction
and cytotoxicity. It might reflect a multi-faceted event of cellular
regulation of PDI, possibly related to the refined structural
diversities of prion proteins, which also suggests PDI as a target for
easing the neuronal damage and toxic pathology of prion disease.
Nevertheless, both PrP constructs have the ability to induce the
formation of SNO-PDI eventually, which probably contributes to
cytotoxicity of misfolded PrP proteins in cultured cells and to
irreversible neuron damage in prion infections at a late stage.
Supporting Information
Figure S1 Co-localizations of the expressed PrPs and Golgi
compartment in 293-T cells. Cells receiving various PrP constructs
were immunocytochemically stained 48 h after transfection. The
images of PrP (green), Golgi (red), DAPI (blue) and merge are
monitored under a confocal microscopy and indicated above.
(61000).
(TIF)
Figure S2 Influences of expressions of PS1-KDEL, PrP-G114V
and PrP-PG14 on the cell viability and the relevant cellular factors.
A. Cell viabilities assayed by CCK-8 kit. Each group is assigned to
three repeating parallel units and measured with a spectropho-
tometer under 450 nm. The results are indicated as mean 6 SD.
Statistical differences compared with controls are illustrated as
*P,0.05. B. Western blots. Cell lysates were separated in 15%
SDS-PAGE and the specific immunoblots for Grp78, pro-
caspase12, PDI, pro-caspase3 and PrP were detected with
individual antibodies. C. Quantitative analysis of each gray
numerical value of Grp78, pro-caspase12, PDI, pro-caspase3 vs
that of individual b-actin. The results are calculated from three
independent tests presented as mean 6 SD. Statistical differences
are illustrated as *P,0.05.
(TIF)
Figure S3 Caspase-3 activity assays of various preparations with
a commercial kit. 2 U/ml of recombinant human capsase-3
(marked as Caspase-3) supplied in the kit was used as the positive
control. ABS indicates as absorbance at 405 nm. Test was
repeated for three times. Data are shown as mean values 6 SD.
Statistical differences are illustrated as *P,0.05.
(TIF)
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